Navigation Links
John C. Moran Named CEO at Core Essence Orthopaedics
Date:9/11/2009

YARDLEY, Pa., Sept. 11 /PRNewswire/ -- Core Essence Orthopaedics, Inc., a medical device company focused on soft tissue and skeletal repair of the extremities, announced today that John Moran will serve as Chief Executive Officer as well as Chairman of the Board, effective immediately.

"The addition of John as CEO will greatly benefit the company as it moves from product development to commercialization," said Zev Scherl, member of CE Ortho's Board of Directors and General Partner of NewSpring Capital. "John had tremendous success building a proprietary business during his time as President of Synthes Spine Inc.. In his new role as CEO of CE Ortho he now has a platform to build another highly attractive orthopaedic business."

"I look forward to leading CE Ortho as we begin to execute our sales strategy for our novel extremity products," stated John Moran. "The market opportunity for intuitive, arthroscopic devices in the extremity segment is substantial and to date the reception from surgeons has been very encouraging."

From 1990-1997, Moran founded and served as President of Synthes Spine, a division of Synthes (USA)--a global leader in orthopaedics. At Synthes Spine, Moran played an integral role in the design, manufacture and distribution of implants and instruments for spinal disorders. Moran has been an active angel investor in the medical device arena. He also currently serves on the boards of Power Medical Interventions, Paradigm Spine, and Ranier Technologies. Moran is a graduate of the University of Notre Dame and holds an MBA from Harvard University.

CE Ortho recently received FDA 510(k) clearance for SECURUS(TM), its innovative knotless suture anchor system for rotator cuff repair. SECURUS's intuitive design will allow easier and more certain fixation, along with superior tendon-to-bone footprint pressure to promote healing. SECURUS is specifically designed to give surgeons the motivation to make the transition to minimally invasive surgery at a time when the demand for arthroscopic surgery is greater than ever. The company is initiating sales for its various product lines over the next year.

About Core Essence Orthopaedics, Inc.

Core Essence Orthopaedics, Inc. (CE Ortho) is a privately held orthopaedic device company focused on the development, manufacturing and commercialization of solutions for minimally invasive soft tissue and arthroscopic musculoskeletal repair for the extremity market. CE Ortho's intuitive and innovative technologies are driven by increasing demands for alternatives to complicated surgical procedures. CE Ortho devices enable surgeons to build on classic and familiar surgical techniques with novel instruments and implants that simplify procedures and can be quickly mastered. The Company's proprietary technologies provide solutions to the growing volume of tendon and ligament repairs required by the active lifestyles of patients of all ages. For more company information, visit www.ceortho.com.

    Contact
    Alan Miller
    Executive VP Market and Business Development
    215.310.9534
    Alan.Miller@CEOrtho.com


'/>"/>
SOURCE Core Essence Orthopaedics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Campaign for Americas Future Memorandum: Katrina Storm Warning
2. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
3. DuPont and TERI Sign Memorandum of Understanding on Green Building Design in India
4. Iraqs Ministry of Health and USAID Sign Memorandum of Understanding to Increase Cooperation in Public Management
5. Intercim and Dassault Systemes Sign Memorandum of Understanding
6. Anita Moran AIA Joins WHR Dallas
7. UCLA signs historic memorandum with pediatric institution in Tokyo
8. Statement on Presidential Memorandum to EPA to Review Lifting of Ban on California Clean Car Standard
9. John C. Moran Named Chairman of the Board at Core Essence Orthopaedics
10. The National Health Care Anti-Fraud Association Signs Memorandum of Understanding With Canadian and European Anti-Fraud Organizations
11. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... Pittsburgh, PA (PRWEB) , ... May 26, 2016 ... ... transplantation, and one that has a significant negative impact on long-term patient survival, ... to date. The results, published online this week in the Journal of Thoracic ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James ... Fighting Blindness, Long Island Chapter on June 4, 2016, 1:30-3:30 pm at the ... founder of Retina Group of New York , is a Board Certified ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership of Life ... announced the organization has earned its ISO 13485 certification, indicating the company’s quality ... all rules and policies associated with ISO quality standard 13485. , BSI ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... offering campers a multitude of activities from daily practices, arts & crafts, discussions, ... Camp Directors Amber East-D’Anna and Christy Evans have combined backgrounds in kids’ yoga, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Power Systems, a leading developer ... Instructor Certification Course in Stoughton, Massachusetts. The course was led by Power Systems’ ... 8 hour interactive course to qualify participants as certified PowerWave trainers. , ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... 25, 2016 ReportsnReports.com adds ... report that provides an overview on therapeutic pipeline ... various stages, therapeutics assessment by drug target, mechanism ... molecule type, along with latest updates, and featured ... players involved in the therapeutic development for Chronic ...
(Date:5/24/2016)... 2016   , Study ... overall bowel cleansing and superiority in , ... of the ascending colon ... Norgine B.V. today announced new positive data from the ... bowel preparation) versus standard 2 litre PEG with ascorbate. The study ...
(Date:5/24/2016)... , May 24, 2016 Celsion ... drug development company, today provided an update on ... escalating clinical trial combining GEN-1, the Company,s DNA-based ... treatment of newly-diagnosed patients with advanced ovarian cancer ... debulking surgery.  GEN-1 is an IL-12 DNA plasmid ...
Breaking Medicine Technology: